The Summary Care Record (SCRa) portal is scheduled to be replaced by a new system called the National Care Records Service (NCRS) from September 2023. From now until September, both the SCRa portal and the NCRS portal will be accessible. NCRS and SCR portal differences The NCRS enables pharmacy professionals to: view the previous Summary Care
Read moreThe National Pharmacy Association (NPA) has now nominated its representatives to sit on PSNC (soon to be Community Pharmacy England) for the 2023-2027 term. The following people will represent independent pharmacy owners: Representative name Ian Cubbin Olivier Picard This concludes the appointment and election of committee members. Their role is to govern the work of
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Estradot®) 75micrograms/24hours transdermal patches. MSN/2023/047 Tier 2 – medium impact Date of issue 13th April 2023 Estradiol (Estradot®) 75micrograms/24hours transdermal patches are out of stock until early May 2023. An alternative brand of estradiol patches, Evorel®, available as 75micrograms/24hours can
Read moreIn response to a significant ongoing disruption to the supply of Estradot® 75micrograms/24hours patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 13 April 2023, SSP055 provides that for every Estradot® 75micrograms/24hours patch originally prescribed, one Evorel® 75 patch must be supplied. SSP055, authorised by the Secretary
Read moreNHS England (NHSE) has announced that the Pharmacy Contraception Service will launch from 24th April 2023. This start date for the service has not been agreed with PSNC and is in direct contradiction of our warning to Ministers that no new or expanded services can be rolled out in 2023/24 unless extra funding is put
Read morePSNC’s 2023 Pharmacy Pressures Survey has confirmed the worsening situation for community pharmacies as rising costs and significantly increased workload is putting businesses at greater risk of collapse. The survey of over 6,200 pharmacy premises and 2,000 pharmacy team members shows a very worrying picture of the impact of the current pressures on pharmacies and
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Alfuzosin 10mg modified release tablets. MSN/2023/045 Tier 2 – medium impact Date of issue 12th April 2023 There is limited supply of alfuzosin 10mg modified release tablets until w/c 15th May 2023. Alternative alpha-adrenoceptor blockers licensed for the symptomatic treatment of
Read moreCommunity pharmacy contractors (including head office staff) and community pharmacists are invited to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The
Read morePSNC, working with Kingston University and the Community Pharmacy IT Group (CP ITG), has launched a short survey to gather feedback about EPS Paperless, Outcomes and Trackability. Please complete the short EPS survey here We would appreciate views from community pharmacy teams, including those working within multiple group head offices, who are requested to complete
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions. MSN/2023/044 Tier 2 – medium impact Date of issue 6th April 2023 Clarithromycin 125mg/5ml oral suspension is out of stock until w/c 10th April 2023 Clarithromycin 250mg/5ml oral suspension is in limited supply until w/c
Read more
